Three Prognostic Biomarkers Correlate with Immune Checkpoint Blockade Response in Bladder Urothelial Carcinoma

Table 4

Differences in expression of three genes between responders and nonresponders.

Gene symbol	Description	Drug	AveExpr
AURKA	Aurora kinase A	Anti-PD-L1 (atezolizumab)	5.632	0.0007978
BIRC5	Baculoviral IAP repeat containing 5	Anti-PD-L1 (atezolizumab)	2.755	0.0001359
CKS1B	CDC28 protein kinase regulatory subunit 1B	Anti-PD-L1 (atezolizumab)	1.739	0.001768